Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v7-EN | Version v1-EN | |
---|---|---|
Language | English | English |
Date Updated | 2019-10-31 | 2019-02-14 |
Drug Identification Number | 02248157 | 02248157 |
Brand name | GONAL-F | GONAL-F |
Common or Proper name | follitropin alfa for injection | follitropin alfa for injection |
Company Name | EMD SERONO, A DIVISION OF EMD INC., CANADA | EMD SERONO, A DIVISION OF EMD INC., CANADA |
Ingredients | FOLLITROPIN ALFA | FOLLITROPIN ALFA |
Strength(s) | 77MCG | 77MCG |
Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR SUBCUTANEOUS | INTRAMUSCULAR SUBCUTANEOUS |
Packaging size | 1 vial / flacon | 1 vial / flacon |
ATC code | G03GA | G03GA |
ATC description | GONADOTROPHINS AND OTHER OVULATION STIMULANTS | GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
Reason for discontinuation | Business reasons | Business reasons |
Anticipated discontinuation date | 2019-10-31 | 2019-04-30 |
Actual discontinuation date | 2019-10-31 | |
Remaining supply date | 2019-04-30 | 2019-04-30 |
Discontinuation status | To be discontinued | To be discontinued |
Discontinuation decision reversal | no | no |
Tier 3 Status | No | No |
Information on remaining supply | ||
Company comments | Product is discontinued. Other formats of GONAL-f are still available, please contact EMD Serono Customer Care for any questions at 1-800-387-9749. | Product is discontinued. Other formats of GONAL-f are still available, please contact EMD Serono Customer Care for any questions at 1-800-387-9749. |
Health Canada comments |